ES2175100T3 - Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen. - Google Patents

Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2175100T3
ES2175100T3 ES96919967T ES96919967T ES2175100T3 ES 2175100 T3 ES2175100 T3 ES 2175100T3 ES 96919967 T ES96919967 T ES 96919967T ES 96919967 T ES96919967 T ES 96919967T ES 2175100 T3 ES2175100 T3 ES 2175100T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
compounds
piridazinonas
adrenoceptores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96919967T
Other languages
English (en)
Inventor
Peter Matyus
Laszlo Harsing
Mariann Karim
Judit Kosary
Agnes Papp
Antal Simay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Hungary Pharmaceutical Marketing PLC
Original Assignee
Institute for Drugs Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute for Drugs Research Ltd filed Critical Institute for Drugs Research Ltd
Application granted granted Critical
Publication of ES2175100T3 publication Critical patent/ES2175100T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION ESTA RELACIONADA CON UNA R 2 [3 ([1,4]BENZODIOXAN 2 ILMETILAMINO) 1 PROPIL] 3(2H) PIRIDAZINONA CON LA FORMULA (1), Y CON UNA S 2 [3 ([1,4]BENZODIOXAN 2 ILMETILAMINO) 1 PROPIL] 3(2H) PIRIDAZINONA CON LA FORMULA (2), Y CON LAS SALES ACIDAS DE ADICION DERIVADAS, ASI COMO AQUELLAS COMPOSICIONES FARMACEUTICAS QUE CONTENGAN ESTOS COMPUESTOS. ADEMAS, LA INVENCION ESTA RELACIONADA CON UN PROCESO PARA PREPARAR LOS COMPUESTOS ANTERIORES. LOS NUEVOS COMPUESTOS DE PARTIDA CON LAS FORMULAS (4) Y (5) TAMBIEN FORMAN PARTE DEL OBJETO DE ESTA INVENCION. DE ACUERDO CON ESTA INVENCION, ESTOS COMPUESTOS POSEEN EFECTOS ANTAGONISTAS DE LOS RECEPTORES ADRENERGICOS AL 1 Y AL 2 Y ACTIVIDAD UROGENITAL. EN CONSECUENCIA, SON UTILES EN EL TRATAMIENTO DE LA HIPERPLASIA BENIGNA DE PROSTATA.
ES96919967T 1995-05-29 1996-05-28 Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2175100T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9501560A HU224067B1 (hu) 1995-05-29 1995-05-29 3(2H)-Piridazinon-származékok és e vegyületeket tartalmazó gyógyszerkészítmények
PCT/HU1996/000030 WO1996038441A1 (en) 1995-05-29 1996-05-28 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds

Publications (1)

Publication Number Publication Date
ES2175100T3 true ES2175100T3 (es) 2002-11-16

Family

ID=10986884

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96919967T Expired - Lifetime ES2175100T3 (es) 1995-05-29 1996-05-28 Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen.

Country Status (13)

Country Link
US (2) US6194411B1 (es)
EP (1) EP0869957B1 (es)
JP (2) JP3857313B2 (es)
KR (1) KR100408364B1 (es)
AT (1) ATE214389T1 (es)
AU (1) AU710265B2 (es)
CA (1) CA2222724C (es)
DE (1) DE69619861T2 (es)
DK (1) DK0869957T3 (es)
ES (1) ES2175100T3 (es)
HU (1) HU224067B1 (es)
PT (1) PT869957E (es)
WO (1) WO1996038441A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227237B1 (en) 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
CN101120002A (zh) 2005-02-17 2008-02-06 惠氏公司 环烷基稠合的吲哚、苯并噻吩、苯并呋喃和茚衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195645B (en) * 1985-10-30 1988-06-28 Gyogyszerkutato Intezet Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
EP0869957A2 (en) 1998-10-14
HUT75104A (en) 1997-04-28
HU224067B1 (hu) 2005-05-30
JP3857313B2 (ja) 2006-12-13
DK0869957T3 (da) 2002-07-01
WO1996038441A1 (en) 1996-12-05
KR100408364B1 (ko) 2004-06-14
EP0869957B1 (en) 2002-03-13
PT869957E (pt) 2002-09-30
US6194411B1 (en) 2001-02-27
ATE214389T1 (de) 2002-03-15
JPH11506094A (ja) 1999-06-02
US6248907B1 (en) 2001-06-19
AU710265B2 (en) 1999-09-16
CA2222724A1 (en) 1996-12-05
CA2222724C (en) 2006-05-23
DE69619861D1 (de) 2002-04-18
HU9501560D0 (en) 1995-07-28
JP2006316064A (ja) 2006-11-24
DE69619861T2 (de) 2002-09-26
KR19990022042A (ko) 1999-03-25
AU5842796A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
PE11898A1 (es) Nuevos inhibidores de la farnesiltransferasa, su preparacion y los compuestos farmaceuticos que los contienen
ES2133754T3 (es) Procedimiento de lavado esterilizador.
ES2119984T3 (es) Nuevos compuestos propinil bi-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
IS2598B (is) Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma
ES2142034T3 (es) Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
ES2111092T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
ES2170305T3 (es) Derivados de acido hidroxietilaminosulfamico n-sustituidos utiles como inhibidores de proteasas retroviricas.
AR007241A1 (es) Analogos de 20-epi-16-eno de vitamina d3, composiciones farmaceuticas que los contienen, procedimiento para la preparacion de dichos compuestos yempleo de dichos compuestos para la preparacion de composiciones farmaceuticas
SE8703169D0 (sv) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine, acid addition salts thereof and process for preparing same
ES2120145T3 (es) Compuestos bi-aromaticos acetilenados con grupo adamantilo, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2143734T3 (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2175328T3 (es) Piperidonas como antagonistas de la taquiquinina.
ES2062455T3 (es) Nuevos derivados de benzonaftiridina-1,8, su preparacion y las composiciones que les contienen.
PT96030A (pt) Processo para a preparacao de aminocarbonilcarbamatos relacionados com fisoestigmina e de composicoes farmaceuticas que os contem
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
ES2032317T3 (es) Derivados de quinazolina tetraciclicos, obtencion y empleo.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR004719A1 (es) Compuestos debisindolilmaleimidas con un punte n, n' y formulaciones farmaceuticas que los contienen, dichos compuestos son utiles comointermediarios para preparar otras bisindolilmaleimidas que poseen dicho puente n, n'
ES2060050T3 (es) Beta-tioacrilamidas s-sustituidas y su uso como microbicidas.
UY24882A1 (es) Ácidos 4-fenil-4-ciano-ciclohexanoicos sustituidos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 869957

Country of ref document: ES